Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rank in Stocks #18708
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Share Price
$2.49
Market Cap
$4.47M
Change (1 day)
-4.01%
Change (1 year)
678.16%
Country
MY
Trade BioNexus Gene Lab Corporation (BGLC)

Category

Number of shares outstanding for BioNexus Gene Lab Corporation (BGLC)
Number of shares outstanding as of September 2025: 1.80M
According to BioNexus Gene Lab Corporation latest financial reports and stock price the company's current number of shares outstanding is 1.80M. At the end of December 2023 the company had 1.72M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for BioNexus Gene Lab Corporation (BGLC) from 2016 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 1.80M 0.83%
2024 1.78M 3.47%
2023 1.72M 19.51%
2022 1.44M 0.99%
2021 1.43M 66.36%
2020 857.65K 19.16%
2019 719.74K 30.20%
2018 552.80K -11.11%
2017 621.90K 0.00%
2016 621.90K 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
376.00M 20,828.46%
US
707.30M 39,268.87%
US
80.10M 4,358.21%
US
2.84B 157,753.15%
CN
283.00M 15,652.00%
US